Frontiers in Pharmacology | Drugs Outcomes Research and Policies

Original Research

Accepted on 24 Jan 2025

Exploring information technology utilization and needs in community pharmacies: A cross-sectional survey in Shanghai, China

in Drugs Outcomes Research and Policies

Qin Li
Zhao Jin
Yun Liao
Huihua Dai
Jie Meng
Ling Li

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1554141

Original Research

Published on 24 Jan 2025

Cost-effectiveness analysis of gumarontinib versus savolitinib for the treatment of advanced or metastatic NSCLC with MET exon 14 skipping mutations in China using partitioned survival model

in Drugs Outcomes Research and Policies

Gang Fang
Zhipeng Pi
Yiping An
Xinxin Cao
Wei Li
Xiangjun Zhu
Jinxi Ding

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1400422

218 views

Review

Accepted on 23 Jan 2025

Medication nonadherence definition, measurement, prevalence, and causes: Reflecting on the past 20 years and looking forwards

in Drugs Outcomes Research and Policies

Sarah C E Chapman
Amy Hai Yan Chan

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1465059

Systematic Review

Published on 23 Jan 2025

Comparative efficacy and safety of 20 intravenous pharmaceutical intervention for prevention of etomidate-induced myoclonus: a systematic review and Bayesian network meta-analysis

in Drugs Outcomes Research and Policies

Lu Chen
Pengxiang Zhou
Zhengqian Li
Ziyang Wu
Suodi Zhai

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1507616

204 views

Original Research

Published on 22 Jan 2025

Drivers of innovation value: simulation for new drug pricing evaluation based on system dynamics modelling

in Drugs Outcomes Research and Policies

Qian Xing
Wendi Cheng
Wei Wang
Chunlin Jin
Haiyin Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1474856

345 views

Original Research

Published on 22 Jan 2025

Exploring the hemoglobin-to-red blood cell distribution width ratio (HRR) to peripheral arterial disease nexus: a comprehensive analysis of NHANES data from 1999 to 2004

in Drugs Outcomes Research and Policies

Zhihai Yu
Bin Lu
Rui Han
Can Tu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1529155

122 views

Perspective

Accepted on 20 Jan 2025

Leveraging AI to Optimize Vaccines Supply Chain and Logistics in Africa: Opportunities and Challenges

in Drugs Outcomes Research and Policies

Sulaiman Muhammad Musa
USMAN ABUBAKAR HARUNA
Lukman Jibril Aliyu
Mubarak Zubairu
Don Eliseo Lucero-Prisno III

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1531141

Original Research

Accepted on 20 Jan 2025

Profile of STING agonists and inhibitors research: A bibliometric analysis

in Drugs Outcomes Research and Policies

Xuemei Wang
Qian Wang
Yidan Gao
Lijuan Jiang
Lingli Tang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1528459

Original Research

Accepted on 20 Jan 2025

Association between hyperuricemia and all-cause mortality in people taken Statins: a retrospective cohort study

in Drugs Outcomes Research and Policies

Bin Zhu
Zijun He
Mingfen Wu
Jiping Huo
Zhigang Zhao
Wei Guo
Li Yang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1533709

Review

Accepted on 20 Jan 2025

Advances in Sulodexide Based On Long-term Anticoagulation for Myasthenia Gravis Patient with Giant Thymoma

in Drugs Outcomes Research and Policies

Zhou Liu
Liang Zhang
Wei Peng
Qian qian Chen
Yanguang Hou
LIying Zhan
Guang Li

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1543612

Editorial

Accepted on 20 Jan 2025

Editorial: The Role of Validated Tools, Including Pictorial Aids, to Support Medication Adherence and Counselling

in Drugs Outcomes Research and Policies

Piotr Merks
Agnieszka Neuamann-Podczaska
Régis Vaillancourt

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1561101

Original Research

Published on 20 Jan 2025

Towards implementing new payment models for the reimbursement of high-cost, curative therapies in Europe: insights from semi-structured interviews

in Drugs Outcomes Research and Policies

Thomas Desmet
Sissel Michelsen
Elena Van den Brande
Walter Van Dyck
Steven Simoens
Isabelle Huys

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1397531

345 views

Original Research

Published on 15 Jan 2025

Adding capivasertib to fulvestrant in patients with hormone receptor-positive advanced breast cancer: a cost-effectiveness analysis

in Drugs Outcomes Research and Policies

Yitian Lang
Qingqing Chai
Yan Lin
Bin Wu
Xiaoyan Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1495082

305 views

Original Research

Published on 15 Jan 2025

The efficacy and safety of first-line monotherapies in primary therapy of invasive aspergillosis: a systematic review

in Drugs Outcomes Research and Policies

Yan Chen
Jiaojiao Zhao
Yifei Wang
Long Ge
Joey Sum-wing Kwong
Junjie Lan
Rui Zhang
Huaye Zhao
Linfang Hu
Jiaxue Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1530999

293 views

Original Research

Accepted on 14 Jan 2025

Drug utilization study of antiparkinsonian medication in Romania during 25 years

in Drugs Outcomes Research and Policies

Camelia Bucsa
Denisa Bruhs
Anamaria Apan
Elena Ovidia Francu
Cristina Mogosan
Irina Iaru

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1534344

Review

Published on 14 Jan 2025

Discussion on the optimization of personalized medication using information systems based on pharmacogenomics: an example using colorectal cancer

in Drugs Outcomes Research and Policies

Mengying Yuan
Yuankun Zheng
Fei Wang
Niuniu Bai
Haoling Zhang
Yuan Bian
Hao Liu
Xia He

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1516469

172 views

Navigation group

Articles

Exploring information technology utilization and needs in community pharmacies: A cross-sectional survey in Shanghai, China

Cost-effectiveness analysis of gumarontinib versus savolitinib for the treatment of advanced or metastatic NSCLC with MET exon 14 skipping mutations in China using partitioned survival model

Medication nonadherence definition, measurement, prevalence, and causes: Reflecting on the past 20 years and looking forwards

Comparative efficacy and safety of 20 intravenous pharmaceutical intervention for prevention of etomidate-induced myoclonus: a systematic review and Bayesian network meta-analysis

Drivers of innovation value: simulation for new drug pricing evaluation based on system dynamics modelling

Exploring the hemoglobin-to-red blood cell distribution width ratio (HRR) to peripheral arterial disease nexus: a comprehensive analysis of NHANES data from 1999 to 2004

Leveraging AI to Optimize Vaccines Supply Chain and Logistics in Africa: Opportunities and Challenges

Profile of STING agonists and inhibitors research: A bibliometric analysis

Association between hyperuricemia and all-cause mortality in people taken Statins: a retrospective cohort study

Advances in Sulodexide Based On Long-term Anticoagulation for Myasthenia Gravis Patient with Giant Thymoma

Editorial: The Role of Validated Tools, Including Pictorial Aids, to Support Medication Adherence and Counselling

Towards implementing new payment models for the reimbursement of high-cost, curative therapies in Europe: insights from semi-structured interviews

Adding capivasertib to fulvestrant in patients with hormone receptor-positive advanced breast cancer: a cost-effectiveness analysis

The efficacy and safety of first-line monotherapies in primary therapy of invasive aspergillosis: a systematic review

Drug utilization study of antiparkinsonian medication in Romania during 25 years

Discussion on the optimization of personalized medication using information systems based on pharmacogenomics: an example using colorectal cancer